<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="662">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395664</url>
  </required_header>
  <id_info>
    <org_study_id>H-20021500</org_study_id>
    <nct_id>NCT04395664</nct_id>
  </id_info>
  <brief_title>Arrhythmias in Patients With COVID-19</brief_title>
  <acronym>ACOVID</acronym>
  <official_title>The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev and Gentofte Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev and Gentofte Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective clinical cohort study of consecutive patients hospitalized at all
      hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The
      investigators aim to examine if continuous ECG monitoring can be used to understand the
      contribution of COVID-19 infection in the acute phase to the development of cardiac
      arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the
      investigators aim to examine if continuous ECG monitoring - alone and in combination with
      biomarkers - can be used to detect early signs of cardiac complications and predict long-term
      risk of cardiovascular morbidity and mortality following COVID-19 infection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 16, 2020</start_date>
  <completion_date type="Actual">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>COVID-19</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C3+ Holter Monitor</intervention_name>
    <description>ECG monitoring</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        In.patients from hospitals of the greater Copenhagen area
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a
             laboratory confirmed diagnosis of COVID-19 &gt; 18 years of age.

        Exclusion Criteria:

          -  Persons not able to cooperate

          -  Persons unable to understand and sign &quot;informed consent&quot;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Cardiology, Herlev &amp; Gentofte Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hellerup</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>September 6, 2020</last_update_submitted>
  <last_update_submitted_qc>September 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev and Gentofte Hospital</investigator_affiliation>
    <investigator_full_name>Morten Lamberts</investigator_full_name>
    <investigator_title>Associate Professor and Research Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

